OSG
Octave Specialty Group IncPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA margin to shareholders (Insurance Distribution) non-GAAP | 32% | Q1 2026 | — |
| Adjusted EBITDA to Shareholders (Everspan) non-GAAP | 1.6M | Q1 2026 | — |
| Adjusted EBITDA to Shareholders (Insurance Distribution) non-GAAP | 25M | Q1 2026 | — |
| Adjusted net income (Everspan) non-GAAP | 1.2M | Q1 2026 | — |
| Gross premiums written (Everspan) | 104M | Q1 2026 | — |
| Loss ratio (Everspan active programs) | 57% | Q1 2026 | — |
| Net premiums written (Everspan) | 32M | Q1 2026 | — |
| Organic revenue growth (Insurance Distribution) | 42% | Q1 2026 | — |
| Pre-tax income margin to shareholders (Insurance Distribution) | 16% | Q1 2026 | — |
| Total P&C premium production | 531M | Q1 2026 | — |
|
|
|||
| Total revenue (Insurance Distribution Segment) | 79M | Q1 2026 | — |
| adjusted EBITDA to shareholders non-GAAP | $20.1M | Q1 2026 call | — |
| adjusted EBITDA to shareholders margin non-GAAP | 32.3% | Q1 2026 call | — |
| adjusted net income to shareholders non-GAAP | $16.6M | Q1 2026 call | — |
| adjusted net income to shareholders per share non-GAAP | $0.37 | Q1 2026 call | — |
| Everspan accident year loss ratio | 54% | Q1 2026 call | — |
| Everspan active programs loss ratio | 57% | Q1 2026 call | — |
| Everspan adjusted EBITDA non-GAAP | $2M | Q1 2026 call | — |
| Everspan combined ratio | 95% | Q1 2026 call | — |
| Everspan gross premiums written | $104M | Q1 2026 call | — |
| Everspan net premiums earned | $20M | Q1 2026 call | — |
| Everspan net premiums written | $32M | Q1 2026 call | — |
| Insurance Distribution adjusted EBITDA non-GAAP | $25M | Q1 2026 call | — |
| Insurance Distribution adjusted EBITDA to shareholders non-GAAP | $25.3M | Q1 2026 call | — |
| Insurance Distribution debt to EBITDA (pro forma TTM) | 3.2 | March 31, 2026 call | — |
| Specialty Property & Casualty adjusted EBITDA non-GAAP | $1.6M | Q1 2026 call | — |
| Insurance Distribution Segment Adjusted EBITDA to Shareholders non-GAAP | $7M | the fourth quarter | — |
| Insurance Distribution Segment Commission Income | $37M | the fourth quarter | — |
| Insurance Distribution Segment Organic revenue growth | 8.1% | the fourth quarter | — |
| Specialty P&C Insurance (Everspan) Gross premiums written | $80M | the fourth quarter | — |
| Specialty P&C Insurance (Everspan) Net premiums written | $23M | the fourth quarter | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Insurance - Specialty — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSG
this stock
Octave Specialty Group Inc
|
$275.93M | -21.2% | +132.6% | — | 2.9% |
|
FNF
Fidelity National Financial, Inc.
|
$13.47B | -6.3% | +5.6% | 17.8 | 3.3% |
|
RYAN
Ryan Specialty Holdings, Inc.
|
$11.01B | -18.8% | +21.3% | — | 5.7% |
|
AXS
Axis Capital Holdings Ltd
|
$8.44B | +7.4% | +9.9% | 8.6 | 3.0% |
|
FAF
First American Financial Corp
|
$7.14B | +15.0% | +21.6% | 10.8 | 6.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSG | -4.5% | +10.9% | +1.2% | -1.8% | -21.2% |
| SPY | -0.3% | +1.6% | +8.3% | +0.3% | +9.9% |
| vs SPY | -4.2% | +9.3% | -7.2% | -2.1% | -31.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.